Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis
about
Lipid-lowering efficacy of atorvastatinHMG CoA reductase inhibitors (statins) for dialysis patientsKidney Transplantation in the Diabetic PatientPharmacologic management of chronic reno-cardiac syndromeLipid abnormalities in kidney disease and management strategiesDietary Interventions for Type 2 Diabetes: How Millet Comes to HelpRosuvastatin calcium in acute coronary syndromes.HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients.Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis.The effects of different doses of atorvastatin on serum lipid profile, glycemic control, and liver enzymes in patients with ischemic cerebrovascular accident.Survival Benefit of Statins in Hemodialysis Patients Awaiting Renal TransplantationMeta-analysis of statin therapy in maintenance dialysis patients.A meta-analysis of the effects of statin treatment on cardiovascular events and all-cause mortality in diabetic dialysis patientsEffects of statins on cardiorenal syndrome.What's the Optimal Lipids Level for Dialysis Patients? A Cohort Study from a Chinese Dialysis Center in a University Hospital.Statins for renal patients: a fiddler on the roof?Diagnosis and treatment of coronary artery disease in hemodialysis patients evaluated for transplantContemporary Management of Coronary Artery Disease and Acute Coronary Syndrome in Patients with Chronic Kidney Disease and End-Stage Renal Disease.Dyslipidemia in patients with chronic and end-stage kidney disease.Statins in the management of dyslipidemia associated with chronic kidney disease.Is lipid management effective for all stages of CKD?.Reasons for the lack of salutary effects of cholesterol-lowering interventions in end-stage renal disease populations.Statin wars: the heavyweight match--atorvastatin versus rosuvastatin for the treatment of atherosclerosis, heart failure, and chronic kidney disease.Serum lipids and prevention of atherosclerotic cardiovascular events in hemodialysis patients.Results of the 4D study: ten years of follow-up?Safety and efficacy of statins in patients with end-stage renal disease.Dyslipidemia in Dialysis Patients.Does pharmacotherapy improve cardiovascular outcomes in hemodialysis patients?HDL abnormalities in nephrotic syndrome and chronic kidney disease.Lipid lowering in renal disease.Pharmacokinetic and pharmacodynamic profile of rosuvastatin in patients with end-stage renal disease on chronic haemodialysis.Pharmacologic treatment in dialysis patients hospitalized for cardiovascular reasons: do we follow the guidelines?Regional evidence and international recommendations to guide lipid management in Asian patients with type 2 diabetes with special reference to renal dysfunction.Still a reasonable goal: Targeting cholesterol in dialysis and advanced chronic kidney disease patients.Anti-atherosclerotic activity of root bark of Premna integrifolia Linn. in high fat diet induced atherosclerosis model rats.Japanese Society for Dialysis Therapy guidelines for management of cardiovascular diseases in patients on chronic hemodialysis.High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease.Predictors of atherosclerotic events in patients on haemodialysis: post hoc analyses from the AURORA study.Determinants of coronary artery calcification in maintenance hemodialysis patients.Beneficial effect of statins in patients receiving chronic hemodialysis following percutaneous coronary intervention: A nationwide retrospective cohort study.
P2860
Q24187301-24CBF196-B013-44B1-8DB5-43FAF98EF169Q24198108-0579CDE5-231C-4DBD-8030-A978E825EE91Q26799452-0A2D7E5C-DC36-4707-BB35-C41832853AF2Q26829812-322A1C83-DE46-4859-8C63-7198E6EECD6EQ27024982-CD17ADD4-ADF1-4271-8B70-E844052717DEQ28079718-BDA9A4B8-AFD0-4F06-ABEA-4132A5E8D976Q34338367-32595BD0-27D8-401D-927B-E9AC9A683F08Q35027220-5A8E50B8-17F9-4C8B-AF6C-AB1B0BA73C68Q35051225-EAC656E5-6E61-4AA7-81EF-A489EE9691F3Q35160603-A4D7B3B2-C7BE-40AC-B7CB-70DD02DEF989Q35675305-D8CB3F63-3BE3-438F-BD08-84F7F20DD24EQ35682013-7DCD38EB-0016-4B69-8B2F-D797C7EF39C4Q35756365-83F27242-F7EE-476A-B825-EB7C8991879FQ36077149-2E195CB6-56C2-452E-9D37-088829D47FF8Q36228385-CEFDBD04-E133-48E2-8FBC-7DB6E80B849EQ36361057-C6255CC9-A22A-4858-BE63-B6FE2FF760BBQ36555462-AC046A50-3509-40F3-9819-B3F701390DC6Q36721107-F0B934BC-EC34-4A48-AF48-9DC08F96926DQ37447007-743773C7-4C06-4C0E-A4CB-57243CC9531FQ37986355-862C40BD-3D80-4952-9802-BC084CC4AB98Q38076216-6C940DF4-A1F6-4EC2-8378-13C414289053Q38076217-3D96543A-AC98-4333-8B37-EA583F887C86Q38079913-B24C0250-0825-420D-9793-07A0E0A723DEQ38144931-F9506218-3C6F-486C-B3AC-648B12C45D21Q38156020-EA59666A-7180-4800-AC57-9226311E2149Q38164683-9CE32BFA-5A86-40D8-97F2-42B33EB1DA85Q38412228-D0CEDCCE-0551-4345-B4EA-D2940FA9822BQ38602442-CCC52844-4958-4FE8-9E38-483B8FD65D02Q38633497-15FAE8D9-1757-43B9-98DD-7A0B37AD675DQ41690923-BA76DE3F-D22C-483C-9B73-0C6B6BE8AD76Q42692011-4B7CB921-044A-411B-ACAC-AB5CCC641267Q45784975-CE0980DB-6D4C-4274-AA55-9B2F6307E0D2Q47900774-51C782F1-6B5E-4817-B8DA-BB21E61EBA91Q48038746-CA12B192-684B-4D94-AA33-7CD1915EC8DBQ49191105-ADD80C18-1251-4954-8DAE-378057754949Q50502242-3BC04063-5894-4E05-8A23-2C47F0DE0B9CQ51052574-4906B2EF-8A0C-4C2B-9DA1-0B48A054EA0EQ51353168-334C57BF-DD3D-44A4-8236-8A83BF8D795CQ53019639-52CBD07F-8593-4A85-A17F-98117446509CQ55512228-DA8F7194-8A4D-4E48-AF5A-19A340D84B27
P2860
Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Atorvastatin and low-density l ...... litus patients on hemodialysis
@ast
Atorvastatin and low-density l ...... litus patients on hemodialysis
@en
type
label
Atorvastatin and low-density l ...... litus patients on hemodialysis
@ast
Atorvastatin and low-density l ...... litus patients on hemodialysis
@en
prefLabel
Atorvastatin and low-density l ...... litus patients on hemodialysis
@ast
Atorvastatin and low-density l ...... litus patients on hemodialysis
@en
P2093
P2860
P50
P356
P1476
Atorvastatin and low-density l ...... litus patients on hemodialysis
@en
P2093
Bernd Genser
Christiane Drechsler
Christoph Wanner
Eberhard Ritz
German Diabetes and Dialysis Study Investigators
Hallvard Holdaas
Ingar Holme
Karl Winkler
Tatjana Stojakovic
Vera Krane
P2860
P304
P356
10.2215/CJN.09121010
P577
2011-04-14T00:00:00Z